Cagrilintide 5mg + Semaglutide 5mg

This formulation combines Cagrilintide (5mg), a long‑acting amylin‑pathway analogue, with Semaglutide (5mg), a GLP‑1 receptor agonist widely studied for metabolic and appetite‑related signaling. Together, these peptides are frequently used in scientific research exploring dual‑pathway regulation, energy‑balance modeling, and peptide‑hormone interactions.

Researchers employ this combination in in‑vitro studies to evaluate how amylin‑receptor and GLP‑1‑receptor activation may influence satiety signaling, gastric‑emptying pathways, glucose‑related feedback loops, and overlapping endocrine mechanisms. This blend provides an effective model for studying complex multi‑agonist peptide behavior and its impact on metabolic regulation systems.

Components:

• Cagrilintide: 5mg

• Semaglutide: 5mg
  Form: Lyophilized powder
  Purity: ≥99% (HPLC verified)
  Storage: Store at −20°C, protected from light and moisture.